A method for estimating the probability of adverse drug reactions View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1981-08

AUTHORS

C A Naranjo, U Busto, E M Sellers, P Sandor, I Ruiz, E A Roberts, E Janecek, C Domecq, D J Greenblatt

ABSTRACT

The estimation of the probability that a drug caused an adverse clinical event is usually based on clinical judgment. Lack of a method for establishing causality generates large between-raters and within-raters variability in assessment. Using the conventional categories and definitions of definite, probable, possible, and doubtful adverse drug reactions (ADRs), the between-raters agreement of two physicians and four pharmacists who independently assessed 63 randomly selected alleged ADRs was 38% to 63%, kappa (k, a chance-corrected index of agreement) varied from 0.21 to 0.40, and the intraclass correlation coefficient of reliability (R[est]) was 0.49. Six (testing) and 22 wk (retesting) later the same observers independently reanalyzed the 63 cases by assigning a weighted score (ADR probability scale) to each of the components that must be considered in establishing causal associations between drug(s) and adverse events (e.g., temporal sequence). The cases were randomized to minimize the influence of learning. The event was assigned a probability category from the total score. The between-raters reliability (range: percent agreement = 83% to 92%; κ = 0.69 to 0.86; r = 0.91 to 0.95; R(est) = 0.92) and within-raters reliability (range: percent agreement = 80% to 97%; κ = 0.64 to 0.95; r = 0.91 to 0.98) improved (p < 0.001). The between-raters reliability was maintained on retesting (range: r = 0.84 to 0.94; R(est) = 0.87). The between-raters reliability of three attending physicians who independently assessed 28 other prospectively collected cases of alleged ADRs was very high (range: r = 0.76 to 0.87; R(est) = 0.80). It was also shown that the ADR probability scale has consensual, content, and concurrent validity. This systematic method offers a sensitive way to monitor ADRs and may be applicable to postmarketing drug surveillance. Clinical Pharmacology and Therapeutics (1981) 30, 239–245; doi:10.1038/clpt.1981.154 More... »

PAGES

239-245

References to SciGraph publications

  • 1977-03. The ambiguity of adverse drug reactions in EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/clpt.1981.154

    DOI

    http://dx.doi.org/10.1038/clpt.1981.154

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1040267576

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/7249508


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Clinical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug-Related Side Effects and Adverse Reactions", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Evaluation Studies as Topic", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Methods", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Pharmacists", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Physicians", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Probability", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Random Allocation", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "University of Toronto", 
              "id": "https://www.grid.ac/institutes/grid.17063.33", 
              "name": [
                "Clinical Pharmacology Program, Addiction Research Foundation Clinical Institute", 
                "University of Toronto Departments of Medicine and Pharmacology"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Naranjo", 
            "givenName": "C A", 
            "id": "sg:person.01226645005.29", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01226645005.29"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Toronto", 
              "id": "https://www.grid.ac/institutes/grid.17063.33", 
              "name": [
                "Clinical Pharmacology Program, Addiction Research Foundation Clinical Institute", 
                "University of Toronto Departments of Medicine and Pharmacology"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Busto", 
            "givenName": "U", 
            "id": "sg:person.01036404663.38", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036404663.38"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Toronto", 
              "id": "https://www.grid.ac/institutes/grid.17063.33", 
              "name": [
                "Clinical Pharmacology Program, Addiction Research Foundation Clinical Institute", 
                "University of Toronto Departments of Medicine and Pharmacology"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Sellers", 
            "givenName": "E M", 
            "id": "sg:person.066174270.96", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.066174270.96"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Toronto", 
              "id": "https://www.grid.ac/institutes/grid.17063.33", 
              "name": [
                "Clinical Pharmacology Program, Addiction Research Foundation Clinical Institute", 
                "University of Toronto Departments of Medicine and Pharmacology"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Sandor", 
            "givenName": "P", 
            "id": "sg:person.0711274252.36", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0711274252.36"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Toronto", 
              "id": "https://www.grid.ac/institutes/grid.17063.33", 
              "name": [
                "Clinical Pharmacology Program, Addiction Research Foundation Clinical Institute", 
                "University of Toronto Departments of Medicine and Pharmacology"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ruiz", 
            "givenName": "I", 
            "id": "sg:person.074530645.72", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.074530645.72"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Toronto", 
              "id": "https://www.grid.ac/institutes/grid.17063.33", 
              "name": [
                "Clinical Pharmacology Program, Addiction Research Foundation Clinical Institute", 
                "University of Toronto Departments of Medicine and Pharmacology"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Roberts", 
            "givenName": "E A", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Toronto", 
              "id": "https://www.grid.ac/institutes/grid.17063.33", 
              "name": [
                "Clinical Pharmacology Program, Addiction Research Foundation Clinical Institute", 
                "University of Toronto Departments of Medicine and Pharmacology"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Janecek", 
            "givenName": "E", 
            "id": "sg:person.01302114517.07", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01302114517.07"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Toronto", 
              "id": "https://www.grid.ac/institutes/grid.17063.33", 
              "name": [
                "Clinical Pharmacology Program, Addiction Research Foundation Clinical Institute", 
                "University of Toronto Departments of Medicine and Pharmacology"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Domecq", 
            "givenName": "C", 
            "id": "sg:person.055324245.49", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.055324245.49"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Toronto", 
              "id": "https://www.grid.ac/institutes/grid.17063.33", 
              "name": [
                "Clinical Pharmacology Program, Addiction Research Foundation Clinical Institute", 
                "University of Toronto Departments of Medicine and Pharmacology"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Greenblatt", 
            "givenName": "D J", 
            "id": "sg:person.01353142263.05", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01353142263.05"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "https://doi.org/10.1002/j.1552-4604.1979.tb01649.x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1005125861"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/cpt1976195part1489", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1006003488"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/cpt1979255part1493", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1014958015"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/cpt1977213247", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1015234845"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/cpt1979252154", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1019661250"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf00562895", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1023387813", 
              "https://doi.org/10.1007/bf00562895"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf00562895", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1023387813", 
              "https://doi.org/10.1007/bf00562895"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1001/jama.1979.03300070029018", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1042762025"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1981-08", 
        "datePublishedReg": "1981-08-01", 
        "description": "The estimation of the probability that a drug caused an adverse clinical event is usually based on clinical judgment. Lack of a method for establishing causality generates large between-raters and within-raters variability in assessment. Using the conventional categories and definitions of definite, probable, possible, and doubtful adverse drug reactions (ADRs), the between-raters agreement of two physicians and four pharmacists who independently assessed 63 randomly selected alleged ADRs was 38% to 63%, kappa (k, a chance-corrected index of agreement) varied from 0.21 to 0.40, and the intraclass correlation coefficient of reliability (R[est]) was 0.49. Six (testing) and 22 wk (retesting) later the same observers independently reanalyzed the 63 cases by assigning a weighted score (ADR probability scale) to each of the components that must be considered in establishing causal associations between drug(s) and adverse events (e.g., temporal sequence). The cases were randomized to minimize the influence of learning. The event was assigned a probability category from the total score. The between-raters reliability (range: percent agreement = 83% to 92%; \u03ba = 0.69 to 0.86; r = 0.91 to 0.95; R(est) = 0.92) and within-raters reliability (range: percent agreement = 80% to 97%; \u03ba = 0.64 to 0.95; r = 0.91 to 0.98) improved (p < 0.001). The between-raters reliability was maintained on retesting (range: r = 0.84 to 0.94; R(est) = 0.87). The between-raters reliability of three attending physicians who independently assessed 28 other prospectively collected cases of alleged ADRs was very high (range: r = 0.76 to 0.87; R(est) = 0.80). It was also shown that the ADR probability scale has consensual, content, and concurrent validity. This systematic method offers a sensitive way to monitor ADRs and may be applicable to postmarketing drug surveillance. Clinical Pharmacology and Therapeutics (1981) 30, 239\u2013245; doi:10.1038/clpt.1981.154", 
        "genre": "research_article", 
        "id": "sg:pub.10.1038/clpt.1981.154", 
        "inLanguage": [
          "en"
        ], 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1017409", 
            "issn": [
              "0009-9236", 
              "1532-6535"
            ], 
            "name": "Clinical Pharmacology & Therapeutics", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "2", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "30"
          }
        ], 
        "name": "A method for estimating the probability of adverse drug reactions", 
        "pagination": "239-245", 
        "productId": [
          {
            "name": "readcube_id", 
            "type": "PropertyValue", 
            "value": [
              "bfd1934a37060e4cbf6e70b554df488a34546f3caabf1beaafa5a51a83e712a1"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "7249508"
            ]
          }, 
          {
            "name": "nlm_unique_id", 
            "type": "PropertyValue", 
            "value": [
              "0372741"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/clpt.1981.154"
            ]
          }, 
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1040267576"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/clpt.1981.154", 
          "https://app.dimensions.ai/details/publication/pub.1040267576"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2019-04-10T15:18", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8664_00000069.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "http://onlinelibrary.wiley.com/doi/10.1038/clpt.1981.154/abstract"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/clpt.1981.154'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/clpt.1981.154'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/clpt.1981.154'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/clpt.1981.154'


     

    This table displays all metadata directly associated to this object as RDF triples.

    179 TRIPLES      21 PREDICATES      44 URIs      29 LITERALS      17 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/clpt.1981.154 schema:about N3f774d79388c44ff96c178e6af8c060e
    2 N575ab320d4c043398731e415a38eec78
    3 N616cd6e1ec5a49c286adb301d78bc443
    4 N64f08ed93f624b4fa7e0868eb5fa93fc
    5 N6d430b5716d34eeabf6fadfe85f1dce2
    6 N901b8e2ed1f041589f831a82b8c21a6d
    7 N92a67483ee93471f91df48a7ace59f28
    8 N9b9d1b730fb8401fadbc380e1c209ab5
    9 anzsrc-for:11
    10 anzsrc-for:1103
    11 schema:author N7400fc5527804ea09b6a10a05521a5ad
    12 schema:citation sg:pub.10.1007/bf00562895
    13 https://doi.org/10.1001/jama.1979.03300070029018
    14 https://doi.org/10.1002/cpt1976195part1489
    15 https://doi.org/10.1002/cpt1977213247
    16 https://doi.org/10.1002/cpt1979252154
    17 https://doi.org/10.1002/cpt1979255part1493
    18 https://doi.org/10.1002/j.1552-4604.1979.tb01649.x
    19 schema:datePublished 1981-08
    20 schema:datePublishedReg 1981-08-01
    21 schema:description The estimation of the probability that a drug caused an adverse clinical event is usually based on clinical judgment. Lack of a method for establishing causality generates large between-raters and within-raters variability in assessment. Using the conventional categories and definitions of definite, probable, possible, and doubtful adverse drug reactions (ADRs), the between-raters agreement of two physicians and four pharmacists who independently assessed 63 randomly selected alleged ADRs was 38% to 63%, kappa (k, a chance-corrected index of agreement) varied from 0.21 to 0.40, and the intraclass correlation coefficient of reliability (R[est]) was 0.49. Six (testing) and 22 wk (retesting) later the same observers independently reanalyzed the 63 cases by assigning a weighted score (ADR probability scale) to each of the components that must be considered in establishing causal associations between drug(s) and adverse events (e.g., temporal sequence). The cases were randomized to minimize the influence of learning. The event was assigned a probability category from the total score. The between-raters reliability (range: percent agreement = 83% to 92%; κ = 0.69 to 0.86; r = 0.91 to 0.95; R(est) = 0.92) and within-raters reliability (range: percent agreement = 80% to 97%; κ = 0.64 to 0.95; r = 0.91 to 0.98) improved (p < 0.001). The between-raters reliability was maintained on retesting (range: r = 0.84 to 0.94; R(est) = 0.87). The between-raters reliability of three attending physicians who independently assessed 28 other prospectively collected cases of alleged ADRs was very high (range: r = 0.76 to 0.87; R(est) = 0.80). It was also shown that the ADR probability scale has consensual, content, and concurrent validity. This systematic method offers a sensitive way to monitor ADRs and may be applicable to postmarketing drug surveillance. Clinical Pharmacology and Therapeutics (1981) 30, 239–245; doi:10.1038/clpt.1981.154
    22 schema:genre research_article
    23 schema:inLanguage en
    24 schema:isAccessibleForFree false
    25 schema:isPartOf N61356a1103b94575bd1eeb694aa4d406
    26 N7a3b4a70942e4b018b0b8725436dde3e
    27 sg:journal.1017409
    28 schema:name A method for estimating the probability of adverse drug reactions
    29 schema:pagination 239-245
    30 schema:productId N64986a0655f84e7b8cc271b7fab439de
    31 N7045931515a94823abff388c6ef67747
    32 N89ea76efd9de45a2a5e2ed6bbd60e474
    33 Nf1babdb0d6c8498db3ced6b17743649d
    34 Nf5237b611bb1494cbb06507737b8ae8d
    35 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040267576
    36 https://doi.org/10.1038/clpt.1981.154
    37 schema:sdDatePublished 2019-04-10T15:18
    38 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    39 schema:sdPublisher Na28d3580a02e47cf8ebeec1f1750e932
    40 schema:url http://onlinelibrary.wiley.com/doi/10.1038/clpt.1981.154/abstract
    41 sgo:license sg:explorer/license/
    42 sgo:sdDataset articles
    43 rdf:type schema:ScholarlyArticle
    44 N09e65bd853594a93a10be5eca39b4af0 rdf:first N13120c876b1a4689b2c671cd4e0574f4
    45 rdf:rest N9335549d9a854ca68a50f2886bc6f0c8
    46 N13120c876b1a4689b2c671cd4e0574f4 schema:affiliation https://www.grid.ac/institutes/grid.17063.33
    47 schema:familyName Roberts
    48 schema:givenName E A
    49 rdf:type schema:Person
    50 N3154af1794f94ebd863b62e8e3ece013 rdf:first sg:person.0711274252.36
    51 rdf:rest N861a2bc873f64156be7c561f646366be
    52 N39f6aea6a8874106841c5904a99acb70 rdf:first sg:person.055324245.49
    53 rdf:rest N668befe3fd984f14a9a503ed70ee2d47
    54 N3f774d79388c44ff96c178e6af8c060e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    55 schema:name Probability
    56 rdf:type schema:DefinedTerm
    57 N575ab320d4c043398731e415a38eec78 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    58 schema:name Humans
    59 rdf:type schema:DefinedTerm
    60 N61356a1103b94575bd1eeb694aa4d406 schema:issueNumber 2
    61 rdf:type schema:PublicationIssue
    62 N616cd6e1ec5a49c286adb301d78bc443 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    63 schema:name Pharmacists
    64 rdf:type schema:DefinedTerm
    65 N64986a0655f84e7b8cc271b7fab439de schema:name dimensions_id
    66 schema:value pub.1040267576
    67 rdf:type schema:PropertyValue
    68 N64f08ed93f624b4fa7e0868eb5fa93fc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    69 schema:name Methods
    70 rdf:type schema:DefinedTerm
    71 N668befe3fd984f14a9a503ed70ee2d47 rdf:first sg:person.01353142263.05
    72 rdf:rest rdf:nil
    73 N6d430b5716d34eeabf6fadfe85f1dce2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    74 schema:name Drug-Related Side Effects and Adverse Reactions
    75 rdf:type schema:DefinedTerm
    76 N7045931515a94823abff388c6ef67747 schema:name pubmed_id
    77 schema:value 7249508
    78 rdf:type schema:PropertyValue
    79 N7400fc5527804ea09b6a10a05521a5ad rdf:first sg:person.01226645005.29
    80 rdf:rest Na960bde9c798455a85e875b76a07ceaf
    81 N7a3b4a70942e4b018b0b8725436dde3e schema:volumeNumber 30
    82 rdf:type schema:PublicationVolume
    83 N861a2bc873f64156be7c561f646366be rdf:first sg:person.074530645.72
    84 rdf:rest N09e65bd853594a93a10be5eca39b4af0
    85 N89ea76efd9de45a2a5e2ed6bbd60e474 schema:name nlm_unique_id
    86 schema:value 0372741
    87 rdf:type schema:PropertyValue
    88 N901b8e2ed1f041589f831a82b8c21a6d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    89 schema:name Evaluation Studies as Topic
    90 rdf:type schema:DefinedTerm
    91 N92a67483ee93471f91df48a7ace59f28 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    92 schema:name Random Allocation
    93 rdf:type schema:DefinedTerm
    94 N9335549d9a854ca68a50f2886bc6f0c8 rdf:first sg:person.01302114517.07
    95 rdf:rest N39f6aea6a8874106841c5904a99acb70
    96 N9b9d1b730fb8401fadbc380e1c209ab5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    97 schema:name Physicians
    98 rdf:type schema:DefinedTerm
    99 Na28d3580a02e47cf8ebeec1f1750e932 schema:name Springer Nature - SN SciGraph project
    100 rdf:type schema:Organization
    101 Na960bde9c798455a85e875b76a07ceaf rdf:first sg:person.01036404663.38
    102 rdf:rest Naecbb9f19e45421e829e08673797dd8b
    103 Naecbb9f19e45421e829e08673797dd8b rdf:first sg:person.066174270.96
    104 rdf:rest N3154af1794f94ebd863b62e8e3ece013
    105 Nf1babdb0d6c8498db3ced6b17743649d schema:name readcube_id
    106 schema:value bfd1934a37060e4cbf6e70b554df488a34546f3caabf1beaafa5a51a83e712a1
    107 rdf:type schema:PropertyValue
    108 Nf5237b611bb1494cbb06507737b8ae8d schema:name doi
    109 schema:value 10.1038/clpt.1981.154
    110 rdf:type schema:PropertyValue
    111 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    112 schema:name Medical and Health Sciences
    113 rdf:type schema:DefinedTerm
    114 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
    115 schema:name Clinical Sciences
    116 rdf:type schema:DefinedTerm
    117 sg:journal.1017409 schema:issn 0009-9236
    118 1532-6535
    119 schema:name Clinical Pharmacology & Therapeutics
    120 rdf:type schema:Periodical
    121 sg:person.01036404663.38 schema:affiliation https://www.grid.ac/institutes/grid.17063.33
    122 schema:familyName Busto
    123 schema:givenName U
    124 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036404663.38
    125 rdf:type schema:Person
    126 sg:person.01226645005.29 schema:affiliation https://www.grid.ac/institutes/grid.17063.33
    127 schema:familyName Naranjo
    128 schema:givenName C A
    129 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01226645005.29
    130 rdf:type schema:Person
    131 sg:person.01302114517.07 schema:affiliation https://www.grid.ac/institutes/grid.17063.33
    132 schema:familyName Janecek
    133 schema:givenName E
    134 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01302114517.07
    135 rdf:type schema:Person
    136 sg:person.01353142263.05 schema:affiliation https://www.grid.ac/institutes/grid.17063.33
    137 schema:familyName Greenblatt
    138 schema:givenName D J
    139 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01353142263.05
    140 rdf:type schema:Person
    141 sg:person.055324245.49 schema:affiliation https://www.grid.ac/institutes/grid.17063.33
    142 schema:familyName Domecq
    143 schema:givenName C
    144 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.055324245.49
    145 rdf:type schema:Person
    146 sg:person.066174270.96 schema:affiliation https://www.grid.ac/institutes/grid.17063.33
    147 schema:familyName Sellers
    148 schema:givenName E M
    149 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.066174270.96
    150 rdf:type schema:Person
    151 sg:person.0711274252.36 schema:affiliation https://www.grid.ac/institutes/grid.17063.33
    152 schema:familyName Sandor
    153 schema:givenName P
    154 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0711274252.36
    155 rdf:type schema:Person
    156 sg:person.074530645.72 schema:affiliation https://www.grid.ac/institutes/grid.17063.33
    157 schema:familyName Ruiz
    158 schema:givenName I
    159 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.074530645.72
    160 rdf:type schema:Person
    161 sg:pub.10.1007/bf00562895 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023387813
    162 https://doi.org/10.1007/bf00562895
    163 rdf:type schema:CreativeWork
    164 https://doi.org/10.1001/jama.1979.03300070029018 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042762025
    165 rdf:type schema:CreativeWork
    166 https://doi.org/10.1002/cpt1976195part1489 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006003488
    167 rdf:type schema:CreativeWork
    168 https://doi.org/10.1002/cpt1977213247 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015234845
    169 rdf:type schema:CreativeWork
    170 https://doi.org/10.1002/cpt1979252154 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019661250
    171 rdf:type schema:CreativeWork
    172 https://doi.org/10.1002/cpt1979255part1493 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014958015
    173 rdf:type schema:CreativeWork
    174 https://doi.org/10.1002/j.1552-4604.1979.tb01649.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1005125861
    175 rdf:type schema:CreativeWork
    176 https://www.grid.ac/institutes/grid.17063.33 schema:alternateName University of Toronto
    177 schema:name Clinical Pharmacology Program, Addiction Research Foundation Clinical Institute
    178 University of Toronto Departments of Medicine and Pharmacology
    179 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...